Heminevrin

Clomethiazole, the active ingredient in Heminevrin, is a sedative‑hypnotic presented as an oral formulation for oral use. It is employed in the management of alcohol withdrawal, provides sedation, and may be used to treat severe insomnia in adult patients.

GNH USA supplies Heminevrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for regulated medicines, including temperature‑controlled shipping where required and comprehensive regulatory documentation.

Clomethiazole is used in clinical practice to manage conditions related to central nervous system depression and alcohol dependence.

- Alcohol withdrawal syndrome: reduces withdrawal symptoms and prevents progression to severe complications such as seizures. - Sedation: provides controlled sedation for pre‑procedural or intensive care settings. - Insomnia: assists in short‑term management of severe insomnia when other therapies are unsuitable.

Clomethiazole may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Drowsiness: feeling of excessive sleepiness. - Dizziness: light‑headed sensation. - Headache: mild to moderate pain. - Nausea: upset stomach or urge to vomit. - Dry mouth: reduced salivation. - Hypotension: lowered blood pressure.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: elevated liver enzymes or jaundice. - Seizures: occurrence of convulsive episodes. - Cardiac arrhythmia: irregular heart rhythm.

When prescribing clomethiazole, clinicians should observe several safety considerations.

- Liver function: assess hepatic status before initiation and monitor during therapy. - Respiratory status: observe patients with compromised breathing, especially when combined with other depressants. - Concomitant CNS depressants: avoid or use with caution when taken with alcohol, benzodiazepines, opioids, or antihistamines. - Discontinuation: do not stop abruptly; taper the dose to minimise withdrawal effects. - Renal impairment: adjust dosing in severe renal dysfunction if applicable. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Clomethiazole can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Alcohol: additive CNS depression may lead to profound sedation or respiratory failure. - Benzodiazepines and barbiturates: combined effect can cause severe respiratory depression and excessive sedation. - Opioids: risk of profound respiratory compromise and hypotension.

Moderate Interactions (Monitor Closely): - Antidepressants (especially SSRIs): may increase sedation or affect serotonin pathways. - Antihypertensive agents: additive hypotensive effect may require blood pressure monitoring. - Anticholinergic drugs: may exacerbate dry mouth and urinary retention.